(Q33590140)

28 July 2017

Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients (English)

1 reference

28 July 2017

1 reference

Monika Raulf-Heimsoth

4

object named as

Monika Raulf-Heimsoth

0 references

Georg Johnen

object named as

Georg Johnen

9

0 references

Ingrid Sander

object named as

Ingrid Sander

2

0 references

author name string

Irina Raiko

1

1 reference

28 July 2017

Daniel G Weber

3

1 reference

28 July 2017

Monika Raulf-Heimsoth

4

1 reference

28 July 2017

Adrian Gillissen

5

1 reference

28 July 2017

Jens Kollmeier

6

1 reference

28 July 2017

Arnaud Scherpereel

7

1 reference

28 July 2017

Thomas Brüning

8

1 reference

28 July 2017

language of work or name

English

0 references

publication date

28 May 2010

1 reference

28 July 2017

1 reference

28 July 2017

10

1 reference

28 July 2017

242

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-10-242

28 July 2017

0 references

cites work

Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

Serum and pleural fluid biomarkers for mesothelioma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

Biomarkers for malignant pleural mesothelioma: current status

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

Biomarkers for mesothelioma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

Comparison of the Ca2+-binding properties of human recombinant calretinin-22k and calretinin.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

Calretinin-immunoreactivity during postnatal development of the rat isocortex: a qualitative and quantitative study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

Inhibition of the proliferative cycle and apoptotic events in WiDr cells after down-regulation of the calcium-binding protein calretinin using antisense oligodeoxynucleotides

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

Calretinin: a gene for a novel calcium-binding protein expressed principally in neurons

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-10-242

Monoclonal antibodies recognizing epitopes of calretinins: dependence on Ca2+-binding status and differences in antigen accessibility in colon cancer cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-10-242

Soluble mesothelin-related peptides (SMRP) - high stability of a potential tumor marker for mesothelioma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

The calcium-binding protein calretinin-22k is detectable in the serum and specific cells of cancer patients.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

Antibody recognition of calcium-binding proteins depends on their calcium-binding status.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886046

Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin

31 October 2018

1 reference

12 December 2020

Identification of calretinin and the alternatively spliced form calretinin-22k in primary pleural mesotheliomas and in their metastases

1 reference

12 December 2020

Calretinin: A Novel Immunocytochemical Marker for Mesothelioma

1 reference

12 December 2020

Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions

1 reference

12 December 2020

h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-10-242

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference